APA
Urun Y., Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., Ozdemir N., Sendur M. N., Sezer A., Kılıckap S., Utkan G., Akman T., Akbulut H., Celik I. & Abalı H. (20191206). Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Chicago
Urun Yuksel, Yasar H Arzu, Turna Hande, Esin Ece, Sedef A Murat, Alkan Ali, Oksuzoglu Berna, Ozdemir Nuriye, Sendur Ma Nahit, Sezer Ahmet, Kılıckap Saadettin, Utkan Gungor, Akman Tulay, Akbulut Hakan, Celik Ismail and Abalı Huseyin. 20191206. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Harvard
Urun Y., Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., Ozdemir N., Sendur M. N., Sezer A., Kılıckap S., Utkan G., Akman T., Akbulut H., Celik I. and Abalı H. (20191206). Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
MLA
Urun Yuksel, Yasar H Arzu, Turna Hande, Esin Ece, Sedef A Murat, Alkan Ali, Oksuzoglu Berna, Ozdemir Nuriye, Sendur Ma Nahit, Sezer Ahmet, Kılıckap Saadettin, Utkan Gungor, Akman Tulay, Akbulut Hakan, Celik Ismail and Abalı Huseyin. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20191206.